123 related articles for article (PubMed ID: 12837480)
1. Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
Latsch S; Selzer T; Fink L; Kreuter J
Eur J Pharm Biopharm; 2003 Jul; 56(1):43-52. PubMed ID: 12837480
[TBL] [Abstract][Full Text] [Related]
2. Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems.
Latsch S; Selzer T; Fink L; Horstmann M; Kreuter J
Eur J Pharm Biopharm; 2004 Mar; 57(2):397-410. PubMed ID: 15019001
[TBL] [Abstract][Full Text] [Related]
3. Determination of the physical state of norethindrone acetate containing transdermal drug delivery systems by isothermal microcalorimetry, X-ray diffraction, and optical microscopy.
Latsch S; Selzer T; Fink L; Kreuter J
Eur J Pharm Biopharm; 2004 Mar; 57(2):383-95. PubMed ID: 15019000
[TBL] [Abstract][Full Text] [Related]
4. Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems.
Lipp R; Müller-Fahrnow A
Eur J Pharm Biopharm; 1999 Mar; 47(2):133-8. PubMed ID: 10234537
[TBL] [Abstract][Full Text] [Related]
5. Crystallization of beta-estradiol in an acrylic transdermal drug delivery system.
Variankaval NE; Jacob KI; Dinh SM
J Biomed Mater Res; 1999 Mar; 44(4):397-406. PubMed ID: 10397943
[TBL] [Abstract][Full Text] [Related]
6. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
7. Selection and use of crystallization inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids.
Lipp R
J Pharm Pharmacol; 1998 Dec; 50(12):1343-9. PubMed ID: 10052847
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of vitamin E TPGS/HPMC supersaturated system and other solubilizer/polymer combinations to enhance the permeability of a poorly soluble drug through the skin.
Ghosh I; Michniak-Kohn B
Drug Dev Ind Pharm; 2012 Nov; 38(11):1408-16. PubMed ID: 22296239
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of in vitro-in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems.
Yang Y; Manda P; Pavurala N; Khan MA; Krishnaiah YS
J Control Release; 2015 Jul; 210():58-66. PubMed ID: 25979329
[TBL] [Abstract][Full Text] [Related]
10. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems.
Attama AA; Schicke BC; Müller-Goymann CC
Eur J Pharm Biopharm; 2006 Nov; 64(3):294-306. PubMed ID: 16949805
[TBL] [Abstract][Full Text] [Related]
11. Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol.
Kotiyan PN; Vavia PR
Eur J Pharm Biopharm; 2001 Sep; 52(2):173-80. PubMed ID: 11522483
[TBL] [Abstract][Full Text] [Related]
12. Stability of extruded 17 beta-estradiol solid dispersions.
Hülsmann S; Backensfeld T; Bodmeier R
Pharm Dev Technol; 2001; 6(2):223-9. PubMed ID: 11416996
[TBL] [Abstract][Full Text] [Related]
13. A critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil.
Attama AA; Müller-Goymann CC
Int J Pharm; 2006 Sep; 322(1-2):67-78. PubMed ID: 16828247
[TBL] [Abstract][Full Text] [Related]
14. Design and characterization of submicron formulation for a poorly soluble drug: the effect of Vitamin E TPGS and other solubilizers on skin permeability enhancement.
Ghosh I; Michniak-Kohn B
Int J Pharm; 2012 Sep; 434(1-2):90-8. PubMed ID: 22633930
[TBL] [Abstract][Full Text] [Related]
15. The use of isothermal heat conduction microcalorimetry to evaluate drug stability in tablets.
Selzer T; Radau M; Kreuter J
Int J Pharm; 1999 Jul; 184(2):199-206. PubMed ID: 10387949
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mathematical models describing drug release from estradiol transdermal systems.
Costa P; Sousa Lobo JM
Drug Dev Ind Pharm; 2003 Jan; 29(1):89-97. PubMed ID: 12602496
[TBL] [Abstract][Full Text] [Related]
17. Second harmonic generation microscopy as a tool for the early detection of crystallization in spray dried dispersions.
Correa-Soto C; Trasi NS; Schmitt PD; Su Y; Liu Z; Miller E; Variankaval N; Marsac PJ; Simpson GJ; Taylor LS
J Pharm Biomed Anal; 2017 Nov; 146():86-95. PubMed ID: 28866472
[TBL] [Abstract][Full Text] [Related]
18. Effect of impurities on estradiol crystallization in a sustained-release implant.
Needham GF; Pfeiffer RR; Engel GL; Rutherford BS; Allen DJ
J Pharm Sci; 1992 Oct; 81(10):1012-4. PubMed ID: 1432611
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of 17-beta estradiol in a transdermal drug delivery system.
Variankaval NE; Jacob KI; Dinh SM
J Mater Sci Mater Med; 2002 Mar; 13(3):271-80. PubMed ID: 15348624
[TBL] [Abstract][Full Text] [Related]
20. Use of CP/MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms.
Park JS; Kang HW; Park SJ; Kim CK
Eur J Pharm Biopharm; 2005 Aug; 60(3):407-12. PubMed ID: 15996582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
